CCM
GOSS icon

Context Capital Management’s Gossamer Bio GOSS Stock Holding History

Context Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.76M Buy
+361,831
New +$8.08M 0.09% 128

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Context Capital Management's GOSS Position: Q2 2026 in Review

Context Capital Management opened a new position in Gossamer Bio (GOSS) in Q2 2026: 361,831 shares worth $4.76M. The stake represents 0.09% of the portfolio and ranks #128 among its holdings.

166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Context Capital Management held 361,831 shares of Gossamer Bio worth $4.76M as of Q2 2026.
  • Gossamer Bio was a new Context Capital Management position in Q2 2026.
  • Gossamer Bio made up 0.09% of Context Capital Management's portfolio in Q2 2026, its #128 holding.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.